Market Research Logo

Global Infertility Treatment Market Research Report Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
2. MARKET OVERVIEW
2.1. GLOBAL INFERTILITY TREATMENT MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION & SCOPE
2.3. INDUSTRY STRUCTURE
2.4. TOTAL MARKET ANALYSIS
2.4.1. TOP 5 FINDINGS
2.4.2. TOP 5 OPPORTUNITY MARKETS
2.4.3. TOP 5 COMPANIES
2.4.4. TOP 3 COMPETITIVE STRATEGIES
2.5. ESTIMATION ANALYSIS
2.6. STRATEGIC ANALYSIS
2.6.1. INVESTMENT VS. ADOPTION MODEL
2.6.2. 360 DEGREE INDUSTRY ANALYSIS
2.6.3. PORTERS 5 FORCE MODEL
2.6.4. SEE-SAW ANALYSIS
2.6.5. ROI ANALYSIS
2.6.6. GAP ANALYSIS
2.6.7. PATENT ANALYSIS
2.6.8. PRICING ANALYSIS
2.6.9. PIPELINE ANALYSIS
2.6.10. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.7. COMPETITIVE ANALYSIS
2.7.1. KEY STRATEGIES & ANALYSIS
2.7.2. MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS
2.8. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.8.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.8.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.8.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
3. MARKET DETERMINANTS
3.1. MARKET DRIVERS
3.1.1. DECLINE IN FERTILITY RATES
3.1.2. RISING PUBLIC-PRIVATE INVESTMENTS, FUNDS, AND GRANTS
3.1.3. GROWING PUBLIC AWARENESS REGARDING INFERTILITY
3.1.4. INCREASING NUMBER OF FERTILITY CLINICS WORLDWIDE
3.1.5. TECHNOLOGICAL UPGRADATION IN INFERTILITY TREATMENT DEVICES
3.2. MARKET RESTRAINTS
3.2.1. EXPENSIVE ASSISTED REPRODUCTIVE TECHNIQUES IN DEVELOPED MARKETS
3.2.2. GOVERNMENT REGULATIONS FOR CERTAIN INFERTILITY TREATMENT OPTIONS
3.3. MARKET OPPORTUNITIES
3.3.1. USE OF FERTILITY TREATMENT OPTIONS BY SAME-SEX COUPLES AND SINGLE PARENTS
3.3.2. RISING OPPORTUNITIES IN EMERGING MARKETS
3.3.2.1. IMPROVING HEALTHCARE INFRASTRUCTURE
3.3.2.2. INCREASING MEDICAL TOURISM DUE TO LOW TREATMENT COSTS
3.4. MARKET CHALLENGES
3.4.1. GROWING CONCERNS RELATED TO A.R.T. PROCEDURES
3.4.2. REDUCTION IN EFFICACY AMONG OLDER WOMEN
4. MARKET SEGMENTATION
4.1. GLOBAL INFERTILITY TREATMENT MARKET BY PROCEDURE
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION
4.1.5.1. GLOBALASSISTED REPRODUCTIVE TECHNOLOGY MARKET
4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.1.3. KEY PLAYERS & KEY PRODUCTS
4.1.5.1.4. KEY CONCLUSIONS
4.1.5.2. GLOBAL ARTIFICIAL INSEMINATION MARKET
4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.2.3. KEY PLAYERS & KEY PRODUCTS
4.1.5.2.4. KEY CONCLUSIONS
4.1.5.3. GLOBALFERTILITY SURGERIES MARKET
4.1.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.3.3. KEY PLAYERS & KEY PRODUCTS
4.1.5.3.4. KEY CONCLUSIONS
4.2. GLOBAL INFERTILITY TREATMENT MARKET BY PRODUCT TYPE
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION
4.2.5.1. GLOBAL INSTRUMENTS MARKET
4.2.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.3. KEY PLAYERS & KEY PRODUCTS
4.2.5.1.4. KEY CONCLUSIONS
4.2.5.2. GLOBAL MEDIA & CONSUMABLESMARKET
4.2.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.3. KEY PLAYERS & KEY PRODUCTS
4.2.5.2.4. KEY CONCLUSIONS
4.2.5.3. GLOBALACCESSORIESMARKET
4.2.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.3.3. KEY PLAYERS & KEY PRODUCTS
4.2.5.3.4. KEY CONCLUSIONS
4.3. GLOBAL INFERTILITY TREATMENT MARKET BY PATIENT TYPE
4.3.1. MARKET DEFINITION AND SCOPE
4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.3.4. OPPORTUNITY MATRIX
4.3.5. MARKET SEGMENTATION
4.3.5.1. GLOBAL FEMALE INFERTILITY MARKET
4.3.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.1.3. KEY PLAYERS & KEY PRODUCTS
4.3.5.1.4. KEY CONCLUSIONS
4.3.5.2. GLOBAL MALE INFERTILITY MARKET
4.3.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.2.3. KEY PLAYERS & KEY PRODUCTS
4.3.5.2.4. KEY CONCLUSIONS
4.4. GLOBAL INFERTILITY TREATMENTMARKET BY ENDUSER
4.4.1. MARKET DEFINITION AND SCOPE
4.4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.4.4. OPPORTUNITY MATRIX
4.4.5. MARKET SEGMENTATION
4.4.5.1. GLOBAL FRTILITY CENTERS MARKET
4.4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.1.3. KEY PLAYERS & KEY PRODUCTS
4.4.5.1.4. KEY CONCLUSIONS
4.4.5.2. GLOBAL HOSPITALS AND CLINICS MARKET
4.4.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.2.3. KEY PLAYERS & KEY PRODUCTS
4.4.5.2.4. KEY CONCLUSIONS
4.4.5.3. GLOBAL RESEARCH INSTITUTE MARKET
4.4.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.3.3. KEY PLAYERS & KEY PRODUCTS
4.4.5.3.4. KEY CONCLUSIONS
4.4.5.4. GLOBAL CRYOBANKS MARKET
4.4.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.4.3. KEY PLAYERS & KEY PRODUCTS
4.4.5.4.4. KEY CONCLUSIONS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGER & ACQUISITION
5.1.2. LIST OF JOINT VENTURE
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIP
5.2. TOP 10 COMPANY ANALYSIS
6. GEOGRAPHICAL ANALYSIS
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GLOBAL INFERTILITY TREATMENT MARKETBY REGION 2014-2023 ($ MILLION)
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S.
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. RUSSIA
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.4.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. REST OF EUROPE
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.5.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. AUSTRALIA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.4.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. REST OF ASIA PACIFIC
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.5.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
7. COMPANY PROFILES
7.1. THE BAKER COMPANY, INC.(U.S.)
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. STRATEGIC INITIATIVES
7.1.4. SCOT ANALYSIS
7.1.5. STRATEGIC ANALYSIS
7.2. COOK GROUP INCORPORATED (U.S.)
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. STRATEGIC INITIATIVES
7.2.4. SCOT ANALYSIS
7.2.5. STRATEGIC ANALYSIS
7.3. .THE COOPER COMPANIES INC. (U.S.)
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. STRATEGIC INITIATIVES
7.3.4. SCOT ANALYSIS
7.3.5. STRATEGIC ANALYSIS
7.4. ESCO MICRO PTE. LTD. (SINGAPORE)
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. STRATEGIC INITIATIVES
7.4.4. SCOT ANALYSIS
7.4.5. STRATEGIC ANALYSIS
7.5. GENEA LIMITED (AUSTRALIA.)
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. STRATEGIC INITIATIVES
7.5.4. SCOT ANALYSIS
7.5.5. STRATEGIC ANALYSIS
7.6. HALOTECH DNA SL (U.S.)
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. STRATEGIC INITIATIVES
7.6.4. SCOT ANALYSIS
7.6.5. STRATEGIC ANALYSIS
7.7. IRVINE SCIENTIFIC(U.S.)
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. STRATEGIC INITIATIVES
7.7.4. SCOT ANALYSIS
7.7.5. STRATEGIC ANALYSIS
7.8. IVFTECH APS (DENMARK)
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. STRATEGIC INITIATIVES
7.8.4. SCOT ANALYSIS
7.8.5. STRATEGIC ANALYSIS
7.9. IHMEDICAL A/S (U.S.)
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. STRATEGIC INITIATIVES
7.9.4. SCOT ANALYSIS
7.9.5. STRATEGIC ANALYSIS
7.10. PANTARHEI BIOSCIENCE B.V. (U.S.)
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. STRATEGIC INITIATIVES
7.10.4. SCOT ANALYSIS
7.10.5. STRATEGIC ANALYSIS
7.11. KITAZATO (JAPAN)
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. STRATEGIC INITIATIVES
7.11.4. SCOT ANALYSIS
7.11.5. STRATEGIC ANALYSIS
7.12. RINOVUM WOMEN’S HEALTH, LLC. (U.S.)
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. STRATEGIC INITIATIVES
7.12.4. SCOT ANALYSIS
7.12.5. STRATEGIC ANALYSIS
7.13. SCSA DIAGNOSTICS, INC. (U.K.)
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. STRATEGIC INITIATIVES
7.13.4. SCOT ANALYSIS
7.13.5. STRATEGIC ANALYSIS
7.14. THERMO FISHER SCIENTIFIC, INC. (U.S.)
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. STRATEGIC INITIATIVES
7.14.4. SCOT ANALYSIS
7.14.5. STRATEGIC ANALYSIS
7.15. VITROLIFE AB (SWEDEN)
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. STRATEGIC INITIATIVES
7.15.4. SCOT ANALYSIS
7.15.5. STRATEGIC ANALYSIS
LIST OF TABLES
GLOBAL INFERTILITY TREATMENT MARKET BY PROCEDURE ($ MILLION)
GLOBALASSISTED REPRODUCTIVE TECHNOLOGYMARKET BY GEOGRAPHY ($ MILLION)
GLOBAL ARTIFICIAL INSEMINATIONMARKET BY GEOGRAPHY ($ MILLION)
GLOBAL FERTILITY SURGERIESMARKET BY GEOGRAPHY ($ MILLION)
GLOBAL INFERTILITY TREATMENT MARKET BY PRODUCT($ MILLION)
GLOBAL INSTRUMENTS MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL MEDIA AND CONSUMABLES MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL ACESSORIES MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL INFERTILITY TREATMENT MARKET BY PATIENT TYPE ($ MILLION)
GLOBAL FEMALE INFERTILITY TREATMNET MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL MALE INFERTILITY TREATMENT MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL INFERTILITY TREATMENT MARKETBY ENDUSER ($ MILLION)
GLOBAL FERTILITY CENTERS MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL HOSPITALS AND CLINICS MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL RESEARCH INSTITUTE MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL CRYOBANKS MARKET BY GEOGRAPHY ($ MILLION)
NORTH AMERICA INFERTILITY TREATMENT MARKET($ MILLION)
EUROPE INFERTILITY TREATMENT MARKET($ MILLION)
ASIA PACIFIC INFERTILITY TREATMENT MARKET($ MILLION)
REST OF THE WORLD INFERTILITY TREATMENT MARKET($ MILLION)
LIST OF FIGURES
GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGYMARKET ($ MILLION)
GLOBAL ARTIFICIAL INSEMINATION MARKET ($ MILLION)
GLOBAL FERTILITY SURGERIES MARKET ($ MILLION)
GLOBALINSTRUMENTS MARKET ($ MILLION)
GLOBAL MEDIA & CONSUMABLES MARKET ($ MILLION)
GLOBAL ACCESSORIES MARKET ($ MILLION)
GLOBAL FEMALE INFERTILITY TREATMENTMARKET ($ MILLION)
GLOBAL MALE INFERTILITY TREATMENTMARKET ($ MILLION)
GLOBALFERTILITY CENTERS MARKET ($ MILLION)
GLOBALHOSPITALS AND CLINICS MARKET ($ MILLION)
GLOBAL CRYOBANKSMARKET ($ MILLION)
UNITED STATES (U.S.) INFERTILITY TREATMENT MARKET($ MILLION)
CANADA INFERTILITY TREATMENT MARKET($ MILLION)
UNITED KINGDOM (UK) INFERTILITY TREATMENT MARKET($ MILLION)
FRANCE INFERTILITY TREATMENT MARKET($ MILLION)
GERMANY INFERTILITY TREATMENT MARKET($ MILLION)
RUSSIA INFERTILITY TREATMENT MARKET($ MILLION)
R.O.E INFERTILITY TREATMENT MARKET($ MILLION)
INDIA INFERTILITY TREATMENT MARKET($ MILLION)
CHINA INFERTILITY TREATMENT MARKET($ MILLION)
JAPAN INFERTILITY TREATMENT MARKET($ MILLION)
AUSTRALIA INFERTILITY TREATMENT MARKET($ MILLION)
ROAPAC INFERTILITY TREATMENT MARKET($ MILLION)
LATIN AMERICA INFERTILITY TREATMENT MARKET($ MILLION)
MENA INFERTILITY TREATMENT MARKET2014-2023 ($ MILLION)

Global Infertility Treatment Market Research Report Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

Infertility is the inability to get pregnant after a year of unprotected intercourse. Both female and male could be responsible for infertility. There are various infertility treatment methods that includes Fertility Drugs, Artificial Insemination, Reproductive Surgery and In Vitro Fertilization (IVF) .The global Infertility Treatment market is expected to rise at a CAGR of 10.6% during the forecast period 2016-2023. The factors that are driving the market of infertility treatment includes rising infertility cases rising public-private investments/funds, and grants, growing public awareness regarding infertility and the available treatment options and technological upgradation in infertility treatment devices. However the growing concerns related to ART procedures and reduction in efficacy among older women.

Geographically, the infertility treatments market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Globally North America holds the largest share of the infertility treatment market in terms of revenue in 2016, followed by Europe and Asia Pacific region. The factors such as declining fertility rates, high healthcare expenditure, early technological upgradation and adoption, and a rise in the number of same-sex couples are some of the factors that are driving the market in North America region.

The report on global Infertility Treatment market is divided into 4 segments that includes procedure, product type, patient type and end-users. The procedure type segment is further divided into Assisted Reproductive Technology, Artificial Insemination, and Fertility Surgeries. In 2016, the ART is the dominating sub segment in the procedure segment due to rising infertility cases among men & women and high prevalence of lifestyle disorders. The end-user segment of Infertility Treatment includes fertility centers, hospitals & clinics, research institutes, and cryobanks. The fertility centers segment holds the largest share of the infertility treatment market in 2016. On the basis of patient type, the global market for infertility treatment is segmented into male patients and female patients. Report further covers segments of product type which includes instruments, media & consumables, and accessories. Instruments accounted for the largest share of the global infertility treatment market in 2016.

The key players in the infertility treatment market across the world includes Cook Group Incorporated (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Vitrolife AB (Sweden), The Cooper Companies Inc. (U.S.) Esco Micro Pte. Ltd. (Singapore). Other major players include IVFtech ApS (Denmark), Genea Limited (Australia),The Baker Company, Inc. (U.S.), Irvine Scientific (U.S.) and Kitazato (Japan).The companies adopting various strategies such as product launch, acquisition and merger in order tostrengthen their position across the world.

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.


Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;